U.S NEWS

Novavax’s Experimental COVID-19 Vaccine Has 96% Efficacy Rate, Drugmaker Says

novavax’s-experimental-covid-19-vaccine-has-96%-efficacy-rate,-drugmaker-says

The Maryland-based company said Thursday that it was “very encouraged by the data” from its phase 3 clinical trial in the U.K.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *

More in:U.S NEWS